 In this randomised controlled trial of patients with stable angina and documented intermediate coronary disease with indeterminate or grey-zone Fractional Flow Reserve FFR we will randomise patients to either optimal medical therapy alone versus optimal medical therapy with PCI and they will be followed up for the primary endpoint of anginal control as measured by the Seattle Angina Questionnaire at 3 months. 